THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
发明人:
KUNDRA, VIKAS
申请号:
EP11824117
公开号:
EP2613791A4
申请日:
2011.09.08
申请国别(地区):
EP
年份:
2015
代理人:
摘要:
Methods and composition for cell-based therapy as well as somatostatin receptor-based therapy are described. For example, in certain aspects methods for administering an anti-tumor therapy using a signaling defective somatostatin receptor mutant are described. Furthermore, the invention provides compositions and methods involve a somatostatin constitutively active somatostatin receptor mutant.